Clinical outcomes and safety of remdesivir in hospitalized individuals with COVID-19, with or without severe renal impairment

Background: The use of remdesivir in patients with coronavirus disease 2019 (COVID-19) and severe renal impairment has been approved; however, limited clinical data exist. Accordingly, we aimed to compare outcomes and adverse events associated with remdesivir in hospitalized patients with COVID-19,...

詳細記述

書誌詳細

出版年:	Journal of Infection and Public Health
主要な著者:	Min-Chi Chang, Ping-Feng Wu, Yu-Chien Ho, Wen-Ying Lin, Chia-Ying Wu, Szu-Yu Liu, Chia-Jen Liu, Yi-Tsung Lin
フォーマット:	論文
言語:	英語
出版事項:	Elsevier 2024-07-01
主題:	Remdesivir COVID-19 Clinical outcomes Severe renal impairment
オンライン･アクセス:	http://www.sciencedirect.com/science/article/pii/S1876034124001874